Map Home
Type / to search with text or keywords
/
keyboard shortcut: Type "/" on your keyboard for a quick search
Search button
Loading...
Loading...
Scroll left
Grants
Citations
H-Index
Patents
News
Books
Scroll right
Collapse sidebar
Data issues & feedback
Adjust height of sidebar
KMap
Grant
Adjust height of sidebar
KMap
Grant
A Randomized, Double-blind, Placebo-Controlled, Multicenter, Phase 3 Study to Evaluate the Safety, Tolerability, and Efficacy of XEN1101 as Adjunctive Therapy in Primary Generalized Tonic-Clonic Seizu
Active
$444.3K Funding
3 People
External
Related Topics
epilepsy,
clinical trials,
medication,
neurology,
therapy
People
Kirsten Anderson
(CD)
Az Health Sciences Division
﹒Research Compliance Administrator IV
David Labiner
Principal Investigator (PI)
Neurology
﹒Professor
Gustavo Cornejo
(CD)
Az Health Sciences Division
﹒Research Compliance Administrator III
